Amphastar Pharmaceuticals AMPH
$ 50.97
0.47%
Quarterly report 2024-Q2
added 08-09-2024
Country |
USA |
IPO year |
2014 |
Industry |
Drug manufacturers |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Jack Zhang |
Employees in the company |
2 027 |
Shares |
48.3 M |
Market Cap[1] |
$ 2.46 B |
EBITDA (LTM) |
$ 224 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.